MBX Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-32.0M | $-32.1M | $129.0K | $2.0M |
| FY2024 | $-54.7M | $-55.6M | $874.0K | $5.2M |
| FY2025 | $-79.9M | $-81.9M | $1.9M | $8.7M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-32.0M | $-32.1M | $129.0K | $2.0M |
| FY2024 | $-54.7M | $-55.6M | $874.0K | $5.2M |
| FY2025 | $-79.9M | $-81.9M | $1.9M | $8.7M |